Market Closed -
Bombay S.E.
06:28:43 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
272.4
INR
|
-0.46%
|
|
-0.02%
|
+24.26%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
17,485
|
9,097
|
3,614
|
8,754
|
27,235
|
17,595
|
Enterprise Value (EV)
1 |
17,593
|
9,019
|
3,494
|
7,343
|
23,356
|
18,164
|
P/E ratio
|
10.3
x
|
8.01
x
|
15.6
x
|
7.44
x
|
9.68
x
|
19.6
x
|
Yield
|
1.17%
|
2.25%
|
-
|
2.57%
|
0.94%
|
0.87%
|
Capitalization / Revenue
|
1.33
x
|
0.72
x
|
0.33
x
|
0.81
x
|
1.36
x
|
0.83
x
|
EV / Revenue
|
1.34
x
|
0.72
x
|
0.32
x
|
0.68
x
|
1.17
x
|
0.85
x
|
EV / EBITDA
|
5.93
x
|
4.34
x
|
4.22
x
|
3.33
x
|
5.29
x
|
9.95
x
|
EV / FCF
|
50
x
|
15.9
x
|
1,815
x
|
6.44
x
|
9.85
x
|
-5.67
x
|
FCF Yield
|
2%
|
6.31%
|
0.06%
|
15.5%
|
10.1%
|
-17.6%
|
Price to Book
|
3.05
x
|
1.36
x
|
0.57
x
|
1.09
x
|
2.51
x
|
1.48
x
|
Nbr of stocks (in thousands)
|
102,388
|
102,388
|
102,388
|
102,388
|
102,388
|
102,388
|
Reference price
2 |
170.8
|
88.85
|
35.30
|
85.50
|
266.0
|
171.8
|
Announcement Date
|
6/27/18
|
6/27/19
|
7/11/20
|
6/28/21
|
7/1/22
|
6/28/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
13,120
|
12,610
|
10,848
|
10,857
|
19,982
|
21,322
|
EBITDA
1 |
2,967
|
2,079
|
827.9
|
2,207
|
4,414
|
1,826
|
EBIT
1 |
2,663
|
1,718
|
395.1
|
1,719
|
3,876
|
1,313
|
Operating Margin
|
20.3%
|
13.62%
|
3.64%
|
15.84%
|
19.4%
|
6.16%
|
Earnings before Tax (EBT)
1 |
2,530
|
1,689
|
381.6
|
1,571
|
3,754
|
1,294
|
Net income
1 |
1,704
|
1,136
|
231.7
|
1,177
|
2,812
|
898.3
|
Net margin
|
12.99%
|
9.01%
|
2.14%
|
10.84%
|
14.07%
|
4.21%
|
EPS
2 |
16.65
|
11.09
|
2.263
|
11.49
|
27.47
|
8.773
|
Free Cash Flow
1 |
351.8
|
568.8
|
1.925
|
1,141
|
2,370
|
-3,205
|
FCF margin
|
2.68%
|
4.51%
|
0.02%
|
10.51%
|
11.86%
|
-15.03%
|
FCF Conversion (EBITDA)
|
11.86%
|
27.36%
|
0.23%
|
51.68%
|
53.69%
|
-
|
FCF Conversion (Net income)
|
20.64%
|
50.09%
|
0.83%
|
96.93%
|
84.27%
|
-
|
Dividend per Share
2 |
2.000
|
2.000
|
-
|
2.200
|
2.500
|
1.500
|
Announcement Date
|
6/27/18
|
6/27/19
|
7/11/20
|
6/28/21
|
7/1/22
|
6/28/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
109
|
-
|
-
|
-
|
-
|
568
|
Net Cash position
1 |
-
|
78.3
|
121
|
1,411
|
3,879
|
-
|
Leverage (Debt/EBITDA)
|
0.0366
x
|
-
|
-
|
-
|
-
|
0.3113
x
|
Free Cash Flow
1 |
352
|
569
|
1.93
|
1,141
|
2,370
|
-3,205
|
ROE (net income / shareholders' equity)
|
35.1%
|
18.3%
|
3.55%
|
16.3%
|
29.8%
|
7.89%
|
ROA (Net income/ Total Assets)
|
20.7%
|
10.9%
|
2.11%
|
8.45%
|
15.1%
|
3.89%
|
Assets
1 |
8,252
|
10,398
|
10,982
|
13,927
|
18,600
|
23,113
|
Book Value Per Share
2 |
56.00
|
65.20
|
62.30
|
78.40
|
106.0
|
116.0
|
Cash Flow per Share
2 |
2.300
|
5.140
|
19.80
|
22.10
|
41.50
|
34.10
|
Capex
1 |
589
|
1,932
|
1,028
|
610
|
736
|
3,628
|
Capex / Sales
|
4.49%
|
15.32%
|
9.48%
|
5.62%
|
3.68%
|
17.01%
|
Announcement Date
|
6/27/18
|
6/27/19
|
7/11/20
|
6/28/21
|
7/1/22
|
6/28/23
|
|
1st Jan change
|
Capi.
|
---|
| +24.26% | 334M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.26B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|